Halozyme Therapeutics stock hits all-time high at 77.6 USD
PositiveFinancial Markets

Halozyme Therapeutics has reached an all-time high stock price of 77.6 USD, marking a significant milestone for the company. This surge reflects investor confidence and positive market sentiment towards its innovative therapies, which could lead to further growth and investment opportunities in the biotech sector.
— Curated by the World Pulse Now AI Editorial System